Cencora | COR - Cost Of Sales


Cencora reported $83.12B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Ambu A/S DKK 625M 14M Mar/2026
Amplifon EUR -241.7M 701.87M Dec/2025
Apollo Hospitals Enterprise Ltd INR 36.26B 248M Mar/2026
Avanos Medical USD 88M 6.9M Mar/2026
Brookdale Senior Living USD 643.31M 41M Dec/2025
Cencora USD 83.12B 2.35B Dec/2025
Coloplast 2.31B 110M Dec/2025
Convatec Group USD 515.3M 270.15M Dec/2024
Diasorin EUR 101M 7.58M Mar/2026
Encompass Health USD 151.6M 700K Mar/2026
Enovis USD 265.57M 5.95M Mar/2026
GE HealthCare Technologies USD 3.44B 283M Dec/2025
Gulf Medical Proj AED 151.05M 11.52M Dec/2025
Hoya 38.92B 5.18B Mar/2026
Med Life RON 283.78M 123.71M Sep/2025
Oriola-kd EUR 461.6M 35.5M Dec/2025
Rede D'or Sao Luiz BRL 11.12B 4.84B Mar/2026
Siemens Healthineers EUR 3.54B 214M Mar/2026
Solventum Corp USD 911M 60M Mar/2026
Sonova Holding CHF 539.4M 11.5M Dec/2025
Veradigm USD 124.74M 56.25M Dec/2022
Zimmer Biomet Holdings USD 738.3M 231.8M Mar/2026